Polypharmacy in Older Adults
When Deprescribing Improves Mental Health

Psychiatric care for older adults is fundamentally different from care for younger patients — different pharmacokinetics, different comorbidities, different risks. The NIMH — Find Help and geriatric psychiatry bodies have established frameworks that this article draws on in addressing polypharmacy deprescribing elderly. The goal is care that improves quality of life without adding to a medication burden that may already be too heavy.

Polypharmacy in Older Adults — Different Population, Different Approach

Psychiatric care for older adults differs from younger-adult care in important ways. NIMH — Find Help and geriatric psychiatry bodies emphasize:

• Pharmacokinetic and pharmacodynamic changes with age — drugs accumulate differently, sensitivity changes
• High prevalence of polypharmacy — psychiatric medications interact with cardiovascular, metabolic, and other agents
• Increased vulnerability to anticholinergic effects, falls, cognitive side effects, and orthostatic changes
• Different prevalence and presentation of depression, anxiety, and cognitive disorders

Evidence-Based Geriatric Prescribing

Practical principles from APA Practice Guidelines practice guidance and accumulated geriatric psychiatry literature:

• Start low, go slow — but go. Undertreatment is as harmful as overtreatment.
• Favor agents with cleaner pharmacology — minimal anticholinergic burden, fewer cardiovascular effects, lower fall risk.
• Deprescribe deliberately. Many older adults accumulate medications over decades; structured review often reveals discontinuation opportunities.
• Distinguish depression, anxiety, cognitive disorder, and medication effects. A brief review will not do this reliably.

Geriatric psychiatry services and deprescribing address the structured workflow.

When Geriatric Specialty Care Matters

Specialty geriatric psychiatric care is particularly useful when:

• Polypharmacy has accumulated without a recent comprehensive review
• Late-onset depression or anxiety has emerged after age 60
• Cognitive complaints overlap with mood symptoms and need disentangling
• Benzodiazepine use has continued for years without a clear taper plan
• Behavioral symptoms in cognitive disorder require expert management

Polypharmacy in Older Adults — The Clinical Framework

Understanding polypharmacy deprescribing elderly requires more than a definition — it requires the framework a thoughtful clinician brings to the evaluation. The NIMH — Find Help and APA Practice Guidelines publish resources that catalogue the evidence base, but the practical work involves matching evidence to the patient.

This article aims to give patients and families the framework an MD/PhD-trained psychiatrist would explain in clinic — clinically substantive, sourced where it matters, and honest about where uncertainty remains.

Evidence-Based Approaches

Current best practice draws on multiple authoritative sources. NIMH — Find Help and APA Practice Guidelines together provide the bulk of the evidence framework that informs clinical care.

For patients dealing with polypharmacy deprescribing elderly, the meaningful distinction is between care that follows the evidence deliberately and care that follows habit. The difference shows up in outcomes — particularly when first-line approaches have not produced full response.

Common Questions About Polypharmacy in Older Adults

Is it normal for medications to need adjustment as I age?

Yes — pharmacokinetic and pharmacodynamic changes mean doses appropriate at 50 may be too high at 75. APA Practice Guidelines guidance supports structured medication review at older ages.

Are benzodiazepines particularly risky in older adults?

Yes — falls, cognitive impairment, and dependency risks all rise substantially. Many older adults on long-term benzodiazepines benefit from structured tapering with alternative treatment.

Can depression cause memory problems in older adults?

Yes — "pseudodementia" describes how depression can mimic cognitive decline. Treating the depression often produces substantial cognitive recovery.